» Articles » PMID: 12031694

Matrix Metalloproteinase-9 Expression After Myocardial Infarction: Physiological or Pathological?

Overview
Journal Cardiovasc Res
Date 2002 May 29
PMID 12031694
Citations 7
Authors
Affiliations
Soon will be listed here.
Citing Articles

Novel Roles of MT1-MMP and MMP-2: Beyond the Extracellular Milieu.

Maybee D, Ink N, Ali M Int J Mol Sci. 2022; 23(17).

PMID: 36076910 PMC: 9455801. DOI: 10.3390/ijms23179513.


MMP-2 and MMP-9 Polymorphisms and Preeclampsia Risk in Tunisian Arabs: A Case-Control Study.

Ali Gannoun M, Raguema N, Zitouni H, Mehdi M, Seda O, Mahjoub T J Clin Med. 2021; 10(12).

PMID: 34208487 PMC: 8234886. DOI: 10.3390/jcm10122647.


Circulating Proangiogenic Cells and Proteins in Patients with Glioma and Acute Myocardial Infarction: Differences in Neovascularization between Neoplasia and Tissue Regeneration.

Huizer K, Sacchetti A, Dik W, Mustafa D, Kros J J Oncol. 2019; 2019:3560830.

PMID: 31428150 PMC: 6679840. DOI: 10.1155/2019/3560830.


Effects of Curcumin Nanoparticles in Isoproterenol-Induced Myocardial Infarction.

Boarescu P, Chirila I, Bulboaca A, Bocsan I, Pop R, Gheban D Oxid Med Cell Longev. 2019; 2019:7847142.

PMID: 31205590 PMC: 6530192. DOI: 10.1155/2019/7847142.


Early matrix metalloproteinase-9 inhibition post-myocardial infarction worsens cardiac dysfunction by delaying inflammation resolution.

Padmanabhan Iyer R, de Castro Bras L, Patterson N, Bhowmick M, Flynn E, Asher M J Mol Cell Cardiol. 2016; 100:109-117.

PMID: 27746126 PMC: 5319826. DOI: 10.1016/j.yjmcc.2016.10.005.